Build an epilepsy surgical candidate pathway: EMU workup, neuropsych, imaging, and boards.
- User
Build an epilepsy surgical candidate pathway: EMU workup, neuropsych, imaging, and boards.
- Assistant
Epilepsy Surgical Candidate Pathway
This pathway outlines the standard presurgical evaluation for adult patients with drug-resistant focal epilepsy at a Level 4 Epilepsy Center (per NLAEE guidelines). It integrates EMU workup, neuropsychological testing (neuropsych), advanced imaging, and multidisciplinary boards. The goal is to localize the epileptogenic zone (EZ), assess surgical resectability, predict postoperative outcomes (seizure freedom ~60-80%, depending on pathology), and minimize morbidity.
The pathway is iterative: Non-invasive Phase I → If inconclusive, Invasive Phase II → Boards → Surgery (if candidate). Total duration: 3-12 months.
Key Prerequisites
- Inclusion: Focal epilepsy refractory to ≥2 ASMs (trial of 3rd if needed), seizures ≥2/year impairing QOL, no progressive neurology.
- Exclusion: Primary generalized epilepsy, non-compliance, active psychiatric contraindications, unrealistic expectations.
- Team: Epileptologist, neurosurgeon, neuropsychologist, neuroradiologist, neurophysiologist.
Pathway Flowchart (Text-Based)
START: Referral for Refractory Focal Epilepsy │ ├── History/Exam + Routine Labs/EEG (outpatient) │ └── Discordant? → Optimize ASM → Re-refer │ ▼ **PHASE I: Non-Invasive Evaluation** (4-8 weeks) │ ├── **Neuropsych Testing** (baseline cognitive map; Wada/fMRI if temporal) ├── **Imaging Suite** │ ├── 3T MRI (volumetric, epilepsy protocol: T1/T2/FLAIR/SWI) │ ├── PET (FDG: hypometabolism) │ ├── SISCOM/SPECT (ictal hyperperfusion) │ ├── MEG (spike/spike-field) │ └── fMRI/DTI (eloquent cortex/tracts) └── **EMU Workup (Scalp Video-EEG)** (3-10 days inpatient) ├── Capture 3-5 typical seizures + auras ├── Interictal spikes └── Mapping (phase reversal for central) │ ▼ Decision Point └── **EZ Well-Localized + Resectable + >80% VNS-free prediction**? ├── YES → **Boards** → Surgery └── NO → **PHASE II: Invasive** (or VNS/RNS if non-surgical) │ **PHASE II: Invasive EMU** (1-4 weeks; grids/depths/SEEG) ├── Tailored electrode placement (MRI-guided, neuronav) ├── Capture seizures → Resection planning ├── ECoG mapping (language/motor) └── Explant → Repeat Imaging/Neuropsych │ ▼ **MULTIDISCIPLINARY BOARDS** (Weekly Conference; 1-2 hours/case) ├── Present: History, EMU videos/clips, imaging fusion, neuropsych ├── Discuss: EZ hypothesis, risks (e.g., 5-10% memory decline temporal), alternatives ├── Consensus: │ ├── Surgical Candidate → Proceed (Resection/Laser/DBS) │ ├── Borderline → Repeat study/optimize │ └── Non-Candidate → Palliative (VNS/RNS/Ketogenic) │ ▼ **SURGERY** (if approved) ├── Pre-op: fMRI/DTI/nav plan ├── Post-op: Day 1 EEG/imaging, Neuropsych (1-3 mo), Follow-up EMU (1 yr) └── Outcome Metrics: Engel Class I (seizure-free)Detailed Steps by Component
1. EMU Workup (Core for Seizure Localization)
Phase Duration Goals Outputs Scalp (Phase I) 3-10 days 3-5 seizures, interictals Onset/lateralization; SQUID if equivocal Invasive (Phase II) 7-21 days Precise EZ (SOZ) ECoG spikes/seizure onset; functional mapping - Safety: AED taper supervised; rescue benzos/MIDazolam; 1:3 nurse ratio.
- ~30% cases need invasive.
2. Neuropsychological Testing
- Timing: Early Phase I + post-invasive.
- Battery: IQ, memory (verbal/nonverbal), language, executive, attention; IVP/Wada if dominant temporal.
- fMRI Alternative: Language/memory lateralization (reduces Wada use >70%).
- Goals: Baseline deficits (IQ drop predicts outcome), post-op risk (e.g., >20% verbal memory risk → hippocampal-sparing).
3. Imaging Protocol
Modality Indication Yield 3T MRI All Lesion (70% MTS/lesional) FDG-PET Non-lesional Concordance 60-70% Ictal SPECT/SISCOM Temporal/non-lesional 80% lateralization MEG Extra-temporal Spike source 50-70% fMRI/DTI/tractography Eloquent-adjacent Avoid deficits - Fusion: Coregister all to MRI (e.g., OsiriX/iPlan).
- Advanced: 7T MRI, AI volumetrics if available.
4. Multidisciplinary Boards
- Format: 10-15 min presentation (epileptologist) + discussion.
- Attendees: 10-20 (neurosurgery, radiology, neuropsych, rehab, nursing).
- Voting: Consensus; document rationale.
- Outcomes:
Decision % Cases Next Resectable 40-50% OR in 4-6 wks Laser/Responsive 20% Proceed Palliative 30% VNS/RNS
Outcomes & Follow-Up
- Success: 60-80% Engel I at 1-2 yrs (temporal > extra-temporal).
- Risks: Infection (1-2% invasive), deficit (5-15%), SD (rare).
- Audit: Track in EPIC/REDCap; quarterly review.
This pathway is adaptable (e.g., pediatric: add SISCOM priority). For implementation, integrate into EMR order sets. Questions? 🕵️♂️
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.